Wernicke's disease may be defined as a neuro logical disorder due to thiamine deficiency of rela tively acute onset, characterized by nystagmus, ex traocular palsies, ataxia, incoordination, and recent memory loss. These symptoms and signs may occur together or in different combinations. Unless treated promptly, the condition may proceed to coma and death. Korsakoff 's psychosis or de mentia refers to the amnestic cognitive disorder that often persists after treatment or spontaneous re covery from Wernicke's disease.
In highly developed countries, Wernicke's en cephalopathy and Korsakoff 's dementia are most commonly encountered as nutritional complications of severe and chronic alcoholism, although they temporoparietal regions. After treatment of compliant pa tients (n = 10), white and gray matter blood flow in creased concurrently with improved CCSE scores. Ab normal eye signs, ataxia, peripheral neuropathy, and per formance of activities of daily living also improved. Cerebral atrophy and ventricular enlargement measured by CT decreased. Early recognition and treatment of WKS in compliant patients permit rapid reversals of cog nitive and neurological impairments associated with in creased blood flow of gray and white matter and improve ments of brain atrophy measured by CT scanning. Key Words: Alcohol-Brain atrophy-Cerebral blood flow-Wernicke-Korsakoff syndrome.
may result from any state of malnutrition leading to thiamine deficiency. They are considered to be two facets of the same disease accompanied by the same neuropathological changes at autopsy (Cravioto et aI., 1961; Victor et aI., 1971; Harper, 1979 Harper, , 1983 Lishman, 1981; To rvik et aI., 1982) . For these rea sons, the symptoms and signs of both conditions are termed Wernicke-Korsakoff syndrome (WKS).
Neuropathological studies carried out in several countries (Cravioto et aI., 1961; Victor et aI., 1971; Lishman, 1981; Harper, 1983) report that the inci dence of Wernicke's encephalopathy diagnosed at autopsy has risen alarmingly in recent years (0.8-2.8% of all necropsies) and appears to be in creasing. In this article a prospective study of 19 new cases of WKS will be reported that were di agnosed in the last year at a large hospital for vet erans serving the southwestern United States. An alarming report of 131 cases of WKS diagnosed at autopsy (Harper, 1983) concluded that only 20% were diagnosed during life, despite the fact that with early diagnosis, treatment results in complete re-covery. In the present study, treatment consisted of withdrawal from alcohol, adequate nutrition, and supplemental thiamine in oral doses of 100 mg three times daily.
Measurements of CBF and metabolism have been reported in patients with chronic alcoholism (Fa zekas and Bessman, 1953; Hedlund et aI., 1964; Ei senberg, 1968; Ingvar et aI., 1969; Berglund and Ingvar, 1976; Heiss et aI., 1976; Berglund and Ris berg, 1977; Kruger and Hoyer, 1979; Berglund et aI., 1980; Johannesson et aI., 1982; Rogers et aI., 1983) . However, few CBF studies have carefully separated WKS patients from chronic alcoholic pa tients displaying neurotoxic effects of alcohol but without WKS. Well-documented patients with re cent WKS in whom CBF measurements were made have been reported by Berglund and Ingvar (1976) , Hedlund et at. (1964) , Fazekas and Bessman (1953) , and Shimojyo et al. (1967) . Prospective longitudinal studies of CBF and neurological and cognitive status examinations correlated with computed to mography (CT) estimates of brain atrophy before and after treatment have not been reported. Brain atrophy in chronic alcoholic patients may occur in the absence of thiamine deficiency or signs of WKS and appears to be due to the neurotoxic effects of excessive and chronic alcohol ingestion, but further research has been recommended to separate these two conditions (Lishman, 1981) .
The present article reports a prospective study among 19 patients with WKS, including serial neu rological and psychometric evaluations that were correlated with measurements of CBF and CT es timates of brain atrophy before and after treatment. A parallel study in patients with signs and symp toms of the neurotoxic effects of chronic alcohol abuse but without WKS will be reported later.
CASE MATERIALS AND METHODS
Ta bles 1 and 2 display demographic data and thera peutic responses among 19 patients with WKS. All cases were men with malnutrition secondary to chronic alcohol abuse treated by the Psychiatry Service at the Veterans Administration Medical Center, Houston, TX, U.S.A., with one exception (case 4). Case 4, who suffered mal nutrition from drug abuse and parenteral feeding during treatment of complicating septicemia, was referred for CBF measurements and medical treatment from the Ben Ta ub General Hospital. Information summarized in Ta bles I and 2 includes patients' age, gender, degree of compli ance with treatment, mental status quantified by the cog nitive capacity scoring examinations (CCSE) (scores of �27 indicate progressively severe degrees of cognitive impairment), presence or absence of abnormal eye signs After  treatment  treatment   15  24  31  15  24  24  31  23  30  16  20  25  27  27  31  19  24  \3  19  20  19  19  14  22  23  25  27  24  29  27  21  18  18  23 20.4 ± 4. 5 25. 3 ± 4.5 \3 improved I worse I no change II  I  II  I  I  II  II  I  II  II  II  II  II  I  I  I  I  I 
12 improved 3 no change CCSE, cognitive capacity screening examination; DNR. did not return; excellent, total withdrawal from alcohol, good diet, plus thiamine administration; poor, partial withdrawal from alcohol, good diet, plus thiamine administration; very poor, heavy alcohol consumption after discharge from hospital, poor diet; +, present; -, absent; ataxic gait: 0, normal; I, mild to moderate; II, wheelchair necessary. a According to Stein and Langfitt (1974) . See Case Materials and Methods for description of the grades. h Nondrinker.
(considered to be characteristic of WKS), degree of ataxic gait, presence or absence of sensory distal periph eral neuropathy, scored activities of daily living (ADL), CT indices of brain atrophy, and median daily intake and duration of alcohol abuse. All patients underwent general medical and neurolog ical examinations, CT scans, and CBF measurements be fore and at intervals after treatment. As expected, not all complied or returned for repeat examinations. Com' plete blood count, blood chemistries, urine analysis, and liver function tests were evaluated in all patients. The age of patients ranged from 30 to 75 years (mean:!: SD, 53. 4 :!: 11. 3 years). Standard treatment programs included signing informed consent agreeing to total confinement for a period of detoxification under medical and psychi atric supervision for 2-8 weeks, total withdrawal from alcohol, psychotherapy, counseling, and provision of a nutritious diet. Dietary intake included three meals a day supervised by a dietitian plus thiamine (vitamin B,) sup plements administered in divided doses of 300 mg/day. Referral to the CBF laboratory and neurological evalua tion were delayed until detoxification was complete (usu ally �4-1O days after admission). This delay was to ex clude any acute effects of alcohol or tranquilizing drugs on CBF measurements and test performances. All seda tive medications were discontinued 48 h prior to referral to the CBF laboratory. Withdrawal symptoms such as seizures and hallucinations were not present in any of the patients at the time of the examinations.
Four patients failed to comply with treatment after dis charge and did not return for follow-up. Among patients
who did comply after discharge, degrees of compliance were classified into three groups: excellent (n = 10) this group complied with total withdrawal from alcohol, followed a nutritious diet, and took 300 mg daily of thia mine; poor (n = 3)-this group withdrew only partially from alcohol consumption after discharge, but followed a good diet and took daily thiamine; very poor (n = 2) this group resumed heavy alcohol consumption after dis charge and followed a poor diet without taking vitamins.
Cognitive deficits were evaluated by the CCSE as de scribed Jacobs et al. (1977) . Scores among normal age matched volunteers range between 29 and 31 with a re producibility error of :!: 1 on sequential examinations in the same individual. The patients' test scores varied be tween 13 and 27 (mean:!: SD, 20. 7 :!: 4.7). The weighting of the CCSE scale is as follows: orientation, 5 points; attention and calculation, 11 points; opposites and simi larities, 5 points; recent memory, 6 points (Kitagawa et aI. , 1984) . All patients showed severe disturbances of re cent memory, compatible with WKS. Degrees of ataxic gait were scored as follows: 0, none; J, mild to moderate; II, confined to wheelchair. Every patient showed ataxia of gait and incoordination of finger to nose testing. Ab normal eye signs consisted of ophthalmoparesis, nys tagmus, and/or pupillary abnormalities. Abnormal eye signs are generally considered to be one of the charac teristic signs in WKS; however, some patients with WKS confirmed by postmortem neuropathological examination did not show abnormal eye signs during life, despite careful neurological examination (Victor et aI. , 1971) . This occurred in five of the present patients. Overall dis-ability, present in all our patients, was assessed by the ADL scale (Stein and Langfitt, 1974) , scored as follows: Grade 0, no deficit recognizable by patient, physician, or family; Grade I, deficits present but patient able to func tion independently at home or at work; Grade II, super vision required at home; Grade III, significant impair ment requiring partial custodial care; Grade IV, contin uous, complete custodial care necessary.
All patients underwent CT scanning before and (if they returned and signed the consent forms) after treatment. CT scans were evaluated by measurement of the size of the lateral and third ventricles and for evidence of hemi spheric and cerebellar cortical atrophy. If the Evans' ratio, ratio of the maximum bifrontal horn diameter to the largest inner skull diameter, exceeded 0.31, this was taken as evidence of cerebral atrophy (Gawler et aI., 1976; Synek et aI. , 1976; LeMay, 1984) . Widening of the vermian sulci of the cerebellum together with enlarge ment of the brainstem cisterns and sulci of the cerebellum is considered evidence of cerebellar atrophy (Haubek and Leek, 1979) . According to these criteria, cerebral atrophy was present in 13 of our patients and cerebellar atrophy in 8.
All patients, except Case 4, gave a history of malnu trition and/or weight loss associated with heavy alcohol consumption. Case 4 was an intravenous heroin abuser who suffered from WKS secondary to malnutrition and vitamin B deficiency worsened by intravenous feeding without vitamin supplementation during recovery from septicemia. In the alcoholic cases, median daily con sumption of alcohol ranged from 80 to 450 g (mean ± SD, 202 ± 126 g). The duration of alcohol consumption ranged from 9 to 44 years (mean ± SD, 25.1 ± 10. 9 years). Delirious and comatose patients were excluded and all were mentally alert at the time of the first exam ination. All met the established diagnostic criteria for di agnosis of WKS recommended by Victor et at. (1971) .
Other exclusion criteria were as follows: history of re cent or remote severe trauma to the head or intracranial surgery, other causes of encephalopathy or associated major psychiatric illnesses, and clinical and/or biochem ical evidence of severe alcoholic hepatitis or cirrhosis. In all cases except one, EEGs were normal (showing 0' and/ or 13 activity) using standard international EEG electrode placement. In the single exception there was a localized focus of e slowing in the right frontal region probably due to cerebral contusion from a remote mild closed head injury. His CT scan showed no localized abnormality and the focal EEG abnormality remained unchanged throughout treatment.
Hyperlipidemia, heart disease, and diabetes mellitus were not present. Three patients (cases 12, 14, and 15) reported a history of labile hypertension; however, blood pressures were within normal limits throughout the pro spective study.
Clinical examinations were repeated 1-4 months (mean 3 months) after treatment in 15 patients, CT scans were repeated in 14 patients, and CBF measurements were re peated in 12 patients. Three compliant patients have con tinued to return for longer follow-up intervals (between 12 and 16 months) and clinical, CBF, and CT improve ments remain sustained. Several patients failed to return for scheduled visits and a few left the laboratory before completing all their scheduled examinations.
Estimates of brain atrophy
CT scans were performed utilizing an EMI 1010 scanner and the 80 by 80 matrix with 8-mm-thick colli mation for each tomographic section. Brain atrophy was measured with a millimeter rule from x-ray transparen cies of the CT scans utilizing standard indices. The fol lowing five indices were utilized: (a) Evans' ratio, which is the ratio of maximal bifrontal horn diameter and the largest diameter of the inner tables of the skull; (b) bi frontal/brain ratio, which is the ratio of maximal bifrontal horn diameter and the internal diameter of the vault of the skull at that level; (c) bicaudate/brain ratio, which is the ratio of the bicaudate diameter and the internal di ameter of the vault of the skull at that level; (d) third ventricle/brain ratio, which is the ratio of the greatest width of the third ventricle and the internal diameter of the vault of the skull at that level; (e) sylvian fissure/brain ratio, which is the ratio of the combined widths of the posterior portions of the two sylvian fissures and the in ternal diameter of the skull vault at that level.
Cerebellar atrophy was qualitatively noted to be present or absent according to criteria described already.
Measurement of regional CBF by 133Xe inhalation
Regional CBF (rCBF) was measured by the 133Xe in halation method (Meyer et al. , 1978) modified after Obrist et al. (1975) . Briefly, 14 collimated, sodium iodide crystal scintillation detectors were mounted in radial array over both hemispheres including frontal, precentral, sylvian opercular, parietal, posterior, and inferior temporal and occipital regions. 133Xe gas mixed with room air (5-8 mCi/L) was inhaled for 1 min by means of a facemask. Clearance curves of 'Y activity from the head and end tidal air were recorded throughout 10 min of de saturation utilizing a minicomputer. Arterial concentrations for I33Xe were estimated from end-tidal air curves. The head curves were dec on voluted using the two-compartmental model for analysis. The faster-clearing compartment (F I ) and the slower-clearing compartment (F2) are considered to represent gray and white matter flows, respectively. The initial slope index values for CBF were also mea sured but they gave the same results as Fl' End-tidal partial pressures for carbon dioxide and oxygen were monitored from the facemask. Blood pressure, EEG, and ECG were also recorded. This method of measuring rCBF records flow values mainly from the superficial parts of each hemisphere. Three-dimensional measure ments of local CBF were also made during CT scanning by inhalation of 37% stable xenon gas, which will be the subject of a later report.
Informed consent
The consent forms used and protocols for measuring CBF by 133Xe and for the CT measurements were ap proved by the Institutional Review Boards of the Vet erans Administration Medical Center and Baylor College of Medicine. Informed consent was signed by all patients and volunteers prior to each procedure.
Methods used for statistical analysis
Values for rCBF, mean bihemispheric CBF, and in dices of brain atrophy were analyzed and compared be tween patients with WKS and age-matched normal vol unteers using Student' s t test. They were also compared before and after treatment using a paired t test. Indices of brain atrophy before and after treatment were analyzed by multivariate analysis of variance. Differences in oc currence of cerebellar atrophy between patients with WKS and normals were analyzed by the l-test. Signifi cance of correlations was tested against the t distribution, and statistical significance was set at p < 0.05.
RESULTS

Clinical evaluations
After hospital confinement and treatment, CCSE scores increased in all cases except one (case 17) who failed to comply with treatment. CCSE scores after treatment (25.3 ± 4.5) were increased signif icantly compared with mean scores before treat ment (20.7 ± 4.7). Case 17 was exceptional because he did not comply with treatment and began drinking alcohol heavily immediately after dis charge from the hospital. As a result, when he re turned for follow-up as an outpatient, his CCSE score had deteriorated further. Abnormal eye signs improved in 7 of 11 cases after treatment. Ataxic gait improved in 12 of the 15 cases returning for follow-up. Signs of sensory neuropathy improved in 8 of the 14 cases. ADL scores improved in 12 of 15 cases. Three patients who did not improve did not comply with treatment.
Estimates of brain atrophy
Ta ble 3 presents degrees of brain atrophy mea sured by CT in patients with WKS compared with age-matched normal volunteers. Four CT indices of ventricular and sulcal volume (Evan's ratio, bi frontal/brain ratio, bicaudate/brain ratio, sylvian fis surelbrain ratio) showed significant atrophy in pa tients with WKS compared with age-matched normal volunteers. The third ventricular ratio did not show significant ventricular enlargement in WKS compared with age-matched normals. Cere bellar atrophy was observed in 8 of the 19 patients with WKS and in 1 of the 19 age-matched normal volunteers. There was a significantly higher frequency of cerebellar atrophy in the WKS group compared with age-matched normals (p < 0.05).
Ta ble 4 compares CT ratios of brain atrophy mea sured before and after treatment in patients with WKS. Among those with excellent compliance, the mean of all CT ratios for brain atrophy showed im provement, indicating increased brain volume. Re sults of individual comparisons of each of the ratios did not reach statistical significance by t test, but each of the ratios of brain atrophy showed signifi cant improvement of brain volume after treatment by multivariate analysis of variance (all univariate comparisons, p < 0.01; overall Wilks lI., p < 0.01). Qualitative estimates of cerebellar atrophy in pa tients with WKS did not significantly change after treatment. Patients with WKS who did not comply with treatment failed to show significant improve ments in brain volume.
Gray and white matter CBF in patients with WKS
End-tidal partial pressure for CO2 and mean ar terial blood pressure values among WKS patients did not differ from those measured in age-matched normal volunteers. Ta ble 5 displays mean values for bihemispheric gray matter (F]) and white matter flow (F2) values measured among patients with WKS. They are both significantly reduced com pared with similar measurements among age matched normal volunteers. No significant differ ences were noted between right and left hemi spheric blood flow reductions.
rCBF reductions in WKS
Figures 1 and 2 illustrate percentage reductions for regional gray (F]) and white (F2) matter blood flow values respectively, in patients with WKS (n = 19) compared with similar measurements among age-matched normal volunteers. There were signif icant reductions of both gray and white matter flow in WKS. These were bilaterally symmetrical, with Figures 5 and 6 illustrate percentage increases in gray and white matter blood flow, respectively, in patients showing excellent compliance with treat ment (n = 9). Both parietotemporal regions show significant increases of both gray and white matter CBF.
DISCUSSION
The present study documents rapid neurologic and cognitive improvement in patients with early WKS treated by abstinence from alcohol (in those in whom the syndrome was alcohol related), nutri tious diet, and thiamine supplementation. [A con trol study is now nearing completion, in which a group of chronic alcoholic patients admitted at the same time without signs of WKS but with neuro toxic symptoms were treated in the same manner by withdrawal from alcohol. They exhibited less marked quantitative increases of gray matter blood flow without changes of white matter flow, which was normal. In chronic alcoholic patients without WKS, gray matter flow reductions were diffuse and regional patterns of flow reduction as seen in WKS were absent.] Quantitative improvements in ab normal eye signs, ataxia of gait, ADL, and CCSE test scores were apparent in WKS patients who complied with treatment. These improver nts cor related with increases of cerebral gray and white matter blood flow. Long-standing and severe cases showed slower and less complete recovery. Patients who complied poorly with treatment showed incon sistent improvement, and those who did not comply at all deteriorated further. Accompanying the clin ical and CBF improvements, CT estimates of brain atrophy showed some evidence of restoration of brain volume as perfusion of gray and white matter increased toward normal.
Brain atrophy in chronic alcoholism and WKS
Neuropathological, pneumoencephalographic, and CT studies of brain atrophy in different alco holic syndromes are summarized in the excellent review of Lishman (1981) . Early reports were con- cerned with pneumoencephalographic measure ments of brain atrophy in chronic alcoholic patients (Hang, 1968; Brewer and Perrett, 1971; Carlsson et al., 1979) . Numerous autopsy reports have con firmed ventricular enlargement and cortical atrophy in chronic alcoholism (Victor et aI., 1959; Lynch and Hill, 1960; Harper and Blumbergs, 1982; Torvik et aI., 1982) . CT studies report brain atrophy during life in young as well as older alcohol abusers (Fox et aI., 1976; Gall et aI., 1978; Cala and Mastaglia, 1980; Kroll et aI., 1980; Lusins et aI., 1980; Carlen et aI., 1981; Ron et aI., 1982; Gurling et aI., 1984) . Cala and Mastaglia (1980) reported that patients with WKS showed greater atrophy of cerebrum, cerebellum, and brainstem compared with chronic alcoholic patients without the syndrome. In the present study, we have confirmed greater degrees of cerebral and cerebellar atrophy by CT in WKS compared with age-matched normal volunteers. Some reversibility of cerebral atrophy following abstinence from alcohol has recently been reported. Carlen et al. (1978) reported partial restitution of brain volume, measured by CT, after abstinence from alcohol in four young alcoholic individuals without WKS. Ron et ai. (1982) also reported im provements in brain atrophy and ventricular volume ratios in chronic alcoholics whose CT scans were repeated 31-91 weeks after abstinence from al- cohol. Reversible brain atrophy has also been ob served in severe malnutrition secondary to anorexia nervosa (Heinz et aI., 1977) . Prospective studies re ported here among WKS patients before and after treatment confirm significant improvements of brain volume in patients of all ages who complied with treatment. Animal models suggest that reex pansion of the brain may be due to removal of the inhibitory effects of alcohol on protein synthesis within the brain. Measurable regrowth of atten uated dendritic and axonal processes in cortical neurons with regeneration of supporting glia has been reported after alcohol withdrawal . In the present study, patients with good compliance showed significant cerebral reex pansion, but those with poor compliance did not, suggesting that abstinence from alcohol plays a major role in reexpansion of brain volume. Wilkinson and Carlen (1980) reported that alco holic patients with WKS showed more severe ce rebral atrophy than those without WKS; however, Carlen et al. (1981) were unable to find significant correlations between cerebral atrophy and thiamine intake. In addition, all patients with chronic mal nutrition may show reexpansion of the brain during treatment by restitution of cerebral blood volume and extracellular and intracellular electrolytes. Pro spective studies of CBF are currently in progress in this laboratory among chronic alcoholic patients without WKS in an effort to clarify this issue.
Cerebral hypoperfusion in WKS and chronic alcoholism Shimojyo et al. (1967) measured CBF and metab olism in 11 patients with acute WKS 5-28 days after thiamine therapy. CBF and oxygen and glu cose consumption remained reduced in all their pa tients. Hedlund et al. (1964) and Kruger and Hoyer (1979) confirmed reductions of CBF and glucose and oxidative metabolism by � 33% in patients with WKS. Berglund and Ingvar (1976) reported normal CBF values after treatment.
Since CBF becomes reduced with normal aging (Naritomi et aI., 1979) , CBF measurements in WKS should be compared with those of age-matched normal volunteers. Comparisons in the present study confirm statistically significant reductions of mean hemispheric gray and white matter blood flow in untreated patients with WKS compared with age matched normal volunteers.
Since CBF is normally coupled with neuronal ac tivity and metabolism, it provides a sensitive indi cator of brain function. CBF measurements in acute WKS demonstrate striking reductions of cerebral perfusion involving both cortex and white matter, particularly evident in both temporal and parietal regions. This cerebral hypoperfusion appears to be brought about by a functional disturbance due to the combined effects of thiamine deficiency and the neurotoxic effects of chronic alcohol ingestion. These observations are consistent with those in an imal models (Henderson et aI. , 1978; Wilkinson and Carlen, 1980) . Part of the reductions of gray matter flow and some of the brain atrophy reported here may be due to the neurotoxic effects of alcohol. All patients except Case 4 (who was known to be vi tamin B] deficient and was not an alcoholic) con sumed >80 g alcohol per day, which defines them as heavy drinkers (Freund, 1973) . Heiss et al. (1976) , Berglund and Ingvar (1976) , Ingvar et al. (1969) , Kruger and Hoyer (1979) , and Rogers et al. (1983) have all reported decreased CBF in chronic alcoholic individuals without WKS.
Biochemical measurements in animal models have confirmed that thiamine deficiency is associ ated with a widespread disorder of neurotransmitter function involving the cortex, midbrain, dienceph alon, and brainstem (Vorhees et aI. , 1977) . Reduc tions in white matter blood flow as seen in our WKS patients have not been observed in parallel studies of chronic alcohol abusers without WKS. This pre sumably reflects the demyelination and microvas cular neuropathology of WKS (Lynch and Hill, 1960; Berglund and Ingvar, 1976) . The neuropath ological changes of WKS have been shown to be brought about by thiamine deficiency and to be re versed by thiamine treatment (Lishman, 1981) . In the present series, case 4 did not abuse alcohol and was treated with diet and thiamine replacement therapy without other vitamin supplements. This resulted in CBF increases, improved recent memory, and reversal of CT evidence of brain atrophy, indicating that thiamine deficiency alone plays a role in reducing cerebral perfusion, partic ularly of white matter as well as gray matter blood flow in both temporal and parietal lobes.
rCBF reductions in WKS
In patients with WKS, although CBF reductions were diffuse, maximal reductions were noted in both temporal and parietal regions, consonant with the cognitive impairments that included severe amnestic difficulties. In human and animal models of WKS, the limbic system shows marked neuro pathological abnormalities and regional reductions of glucose metabolism (Walker et aI., 1980; Hakim and Pappius, 1981) . rCBF of both temporal regions has been shown to be reduced in patients with memory disturbance (Hagberg, 1978; Kitagawa et aI., 1984) .
J Cereb Blood Flow Metabol, Vol. 5, No.3, 1985 Reversal of cerebral hypoperfusion in WKS Rapid improvements of neurological symptoms and signs of WKS after thiamine therapy are well documented (Victor et aI. , 1971) . Fazekas and Bessman (1953) measured CBF and metabolism in a single patient with WKS before and after short term thiamine treatment and reported resultant CBF increases of �5%. In the prospective clinical trial reported here, all patients complying with treatment showed neurological and cognitive im provements associated with large increments of CBF. Patients who failed to comply with treatment showed either no improvement or progressive im pairments of brain function, blood flow, and brain perfusion.
